VAERS Reports HFF8841

VAERS 1795751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge HFF8841

mild

Staat: CA
Alter: 51,0
Geschlecht: F
Eingang: 18.10.2021
Impfdatum: 30.09.2021
Beginn: 01.10.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Diarrhoea Extra dose administered Fatigue Pyrexia

Symptomtext

Low grade fever, fatigue, loose stools

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Undifferentiated Connective Tissue disorder, prior DVT/PE, hypothyroidism, asthma
Vorgeschichte: Undifferentiated Connective Tissue disorder, prior DVT/PE, hypothyroidism, asthma
Andere Medikamente: Plaquenil 400mg, Xarelto 10mg, Vitamin D 5000 IUs
Allergien: None
Vorherige Impfungen: VAERS report was filed by my doctor for life threatening possible reaction to 2nd dose of Pfizer COVID-19 vaccine received 1/30/

VAERS 2414538

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge HFF8841

gering

Staat: CA
Alter: 55,0
Geschlecht: M
Eingang: 18.08.2022
Impfdatum: 01.03.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient. A 56-year-old male patient received BNT162b2 (BNT162B2), in Mar2022 as dose 3 (booster), single (Lot number: HFF8841) at the age of 55 years, in right arm for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Gout" (unspecified if ongoing). Concomitant medication(s) included: ZYLOPRIM oral, start date: Jan2018; ACIPHEX oral. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 included PF-07321332, ritonavir (PAXLOVID) with treatment start date: 11Aug2022, treatment stop date: 16Aug2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: Covid-19 test; Test Result: Positive ; Comments: COVID 19 Treatment
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Gout
Andere Medikamente: ZYLOPRIM; ACIPHEX
Allergien: -
Vorherige Impfungen: -